Bison Wealth LLC Purchases 50,800 Shares of Abacus Life, Inc. (NASDAQ:ABL)

Bison Wealth LLC grew its holdings in Abacus Life, Inc. (NASDAQ:ABL - Free Report) by 492.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 61,125 shares of the company's stock after purchasing an additional 50,800 shares during the quarter. Bison Wealth LLC owned approximately 0.06% of Abacus Life worth $479,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Monashee Investment Management LLC bought a new stake in Abacus Life in the fourth quarter valued at about $6,342,000. Northern Trust Corp increased its stake in Abacus Life by 116.3% in the fourth quarter. Northern Trust Corp now owns 50,626 shares of the company's stock valued at $396,000 after purchasing an additional 27,217 shares in the last quarter. Gratia Capital LLC grew its holdings in shares of Abacus Life by 82.4% in the 4th quarter. Gratia Capital LLC now owns 553,402 shares of the company's stock valued at $4,333,000 after buying an additional 250,000 shares during the period. Mendon Capital Advisors Corp increased its position in shares of Abacus Life by 137.1% in the 4th quarter. Mendon Capital Advisors Corp now owns 1,303,826 shares of the company's stock valued at $10,209,000 after buying an additional 753,826 shares in the last quarter. Finally, Curi RMB Capital LLC raised its stake in Abacus Life by 110.7% during the 4th quarter. Curi RMB Capital LLC now owns 1,159,000 shares of the company's stock worth $9,075,000 after buying an additional 609,000 shares during the period.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ABL shares. Piper Sandler lowered their price target on Abacus Life from $13.00 to $11.50 and set an "overweight" rating for the company in a report on Tuesday, April 8th. B. Riley decreased their price objective on Abacus Life from $17.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Finally, Maxim Group assumed coverage on shares of Abacus Life in a research report on Tuesday, April 29th. They set a "buy" rating and a $14.00 price objective for the company. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $14.00.

Abacus Life Stock Performance

ABL stock traded up $0.02 during trading hours on Friday, reaching $8.27. The stock had a trading volume of 350,483 shares, compared to its average volume of 183,767. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a 50-day simple moving average of $7.66 and a 200 day simple moving average of $7.88. The stock has a market capitalization of $800.97 million, a PE ratio of -45.94 and a beta of 0.16. Abacus Life, Inc. has a fifty-two week low of $6.34 and a fifty-two week high of $12.40.

Abacus Life (NASDAQ:ABL - Get Free Report) last posted its earnings results on Thursday, March 27th. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.03. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The business had revenue of $33.21 million for the quarter, compared to analyst estimates of $28.76 million. Analysts predict that Abacus Life, Inc. will post 0.62 EPS for the current fiscal year.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.